Next, we analyzed the association between upregulated genes with SMA, trying to clarify if there is a universal panel of the secretory protein-coding genes of sarcopenia caused by different tumor types, which would lay the foundation for the development of possible broad-spectrum therapeutic agents. This evidence concerns the gene SMN1 and sarcopenia.